Samarium-based radiopharmaceutical for cancer-related bone pain
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Samarium-based radiopharmaceutical for cancer-related bone pain, covering 2026-01-13 to 2026-01-13. Get the full timeline:
Most recent: Clinical Trial Update: Samarium Optimized for Long-lasting Analgesia in Cancerous End-stage Bone Pain [Phase 1]